China Universal Asset Management Company’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Buy |
13,821
+131
| +1% | +$1.23K | 0.01% | 343 |
|
|
2025
Q1 | $74.2K | Sell |
13,690
-782
| -5% | -$4.24K | 0.01% | 385 |
|
|
2024
Q4 | $108K | Buy |
14,472
+4,179
| +41% | +$31.1K | 0.01% | 383 |
|
|
2024
Q3 | $82.2K | Buy |
10,293
+4,172
| +68% | +$33.3K | 0.01% | 367 |
|
|
2024
Q2 | $53.3K | Sell |
6,121
-3,272
| -35% | -$28.5K | 0.01% | 350 |
|
|
2024
Q1 | $194K | Buy |
9,393
+5,308
| +130% | +$110K | 0.02% | 292 |
|
|
2023
Q4 | $94.4K | Buy |
+4,085
| New | +$94.4K | 0.02% | 287 |
|
|
2022
Q4 | – | Sell |
-319
| Closed | -$3K | – | 418 |
|
|
2022
Q3 | $3K | Buy |
+319
| New | +$3K | ﹤0.01% | 323 |
|